Amylyx Pharmaceuticals, Inc.
AMLX
Rang în acțiuni
#4497
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
Preț acțiune
$27.25
Ultima sincronizare: 2026-10-19
Capitalizare de piață
$3.42B
Schimbare (1 zi)
3.45%
Schimbare (1 an)
77.29%
Țară
US
Tranzacționează Amylyx Pharmaceuticals, Inc. (AMLX)
Categorie
Healthcare
Istoricul randamentului dividendelor pentru Amylyx Pharmaceuticals, Inc. (AMLX)
Randamentul dividendelor (TTM) pentru Amylyx Pharmaceuticals, Inc. (simbol acțiune: AMLX) la data de 2023-12-31 este: 0.00%
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Amylyx Pharmaceuticals, Inc. (AMLX) între 2019 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
| An | Randamentul dividendelor | Schimbă |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Randamentele dividendelor (TTM) pentru companii similare sau concurente
| Companie | Randamentul dividendelor | Țara |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
